Foresight Acquisition Corp. (FORE)
Price:
9.48 USD
( + 0.42 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Churchill Capital Corp X
VALUE SCORE:
7
2nd position
Range Capital Acquisition Corp.
VALUE SCORE:
10
The best
M3-Brigade Acquisition V Corp. Units
VALUE SCORE:
10
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
Foresight Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was founded in 2020 and is based in Chicago, Illinois.
NEWS
FORE Biotherapeutics to Participate in the Wells Fargo Virtual Private Biotech Symposium
businesswire.com
2024-12-05 08:00:00PHILADELPHIA--(BUSINESS WIRE)--FORE Biotherapeutics today announced that the Company will participate in the Wells Fargo Virtual Private Biotech Symposium on Thursday, December 12. William Hinshaw, Chief Executive Officer and Michael Byrnes, Chief Financial Officer, will host and participate in one-on-one meetings. Please contact Argot Partners to schedule one-on-one meetings with the management team. About FORE Biotherapeutics Fore is a registration stage targeted oncology company dedicated to.
P3 Health Partners Announces November Conference Schedule and Virtual Investor Day in Advance of Planned Closing of Business Combination with Foresight Acquisition Corp.
globenewswire.com
2021-11-05 14:38:00NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- P3 Health Partners (“P3”), a patient-centered and physician-led population health management company, which announced earlier this year that it expects to become a public company via a merger with special purpose acquisition company, Foresight Acquisition Corp. (NASDAQ: FORE) (“Foresight”), is scheduled to participate at the following virtual events in November 2021:
P3 Health Partners Sets September 2021 Virtual Conference Schedule
accesswire.com
2021-09-02 17:00:00NEW YORK, NY / ACCESSWIRE / September 2, 2021 / P3 Health Partners ("P3"), a patient-centered and physician-led population health management company, which recently announced its business combination with Foresight Acquisition Corp. (NASDAQ:FORE), a publicly traded special purpose acquisition company, is scheduled to participate at the following virtual financial conferences in September 2021: 10 th Annual Gateway Conference Presentation: Thursday, September 9th at 11:30am Eastern time Webcast: Link Wells Fargo Virtual Healthcare Conference Presentation: Friday, September 10th at 11:20am Eastern time Webcast: Link To receive additional information, request an invitation or to schedule a one-on-one meeting, please contact your Wells Fargo representative or the Company's investor relations team at FORE@gatewayir.com. About P3 Health Partners P3 is a patient-centered and physician-led population health management company.
Moore Kuehn Encourages FMBI, LWAC, LEGO and FORE Investors to Contact Law Firm
prnewswire.com
2021-06-21 13:15:00NEW YORK, June 21, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: First Midwest Bancorp, Inc. (NASDAQ: FMBI) First Midwest has agreed to merge with Old National Bancorp.
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Foresight Acquisition Corp. - FORE
prnewswire.com
2021-06-05 00:09:00NEW YORK, June 5, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Foresight Acquisition Corp. ("FORE" or the "Company") ( FORE ) relating to its proposed merger with P3 Health Partners. Under the terms of the agreement, FORE will acquire P3 through a reverse-merger, with P3 emerging as a publicly traded company.
No data to display
FORE Biotherapeutics to Participate in the Wells Fargo Virtual Private Biotech Symposium
businesswire.com
2024-12-05 08:00:00PHILADELPHIA--(BUSINESS WIRE)--FORE Biotherapeutics today announced that the Company will participate in the Wells Fargo Virtual Private Biotech Symposium on Thursday, December 12. William Hinshaw, Chief Executive Officer and Michael Byrnes, Chief Financial Officer, will host and participate in one-on-one meetings. Please contact Argot Partners to schedule one-on-one meetings with the management team. About FORE Biotherapeutics Fore is a registration stage targeted oncology company dedicated to.
P3 Health Partners Announces November Conference Schedule and Virtual Investor Day in Advance of Planned Closing of Business Combination with Foresight Acquisition Corp.
globenewswire.com
2021-11-05 14:38:00NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- P3 Health Partners (“P3”), a patient-centered and physician-led population health management company, which announced earlier this year that it expects to become a public company via a merger with special purpose acquisition company, Foresight Acquisition Corp. (NASDAQ: FORE) (“Foresight”), is scheduled to participate at the following virtual events in November 2021:
P3 Health Partners Sets September 2021 Virtual Conference Schedule
accesswire.com
2021-09-02 17:00:00NEW YORK, NY / ACCESSWIRE / September 2, 2021 / P3 Health Partners ("P3"), a patient-centered and physician-led population health management company, which recently announced its business combination with Foresight Acquisition Corp. (NASDAQ:FORE), a publicly traded special purpose acquisition company, is scheduled to participate at the following virtual financial conferences in September 2021: 10 th Annual Gateway Conference Presentation: Thursday, September 9th at 11:30am Eastern time Webcast: Link Wells Fargo Virtual Healthcare Conference Presentation: Friday, September 10th at 11:20am Eastern time Webcast: Link To receive additional information, request an invitation or to schedule a one-on-one meeting, please contact your Wells Fargo representative or the Company's investor relations team at FORE@gatewayir.com. About P3 Health Partners P3 is a patient-centered and physician-led population health management company.
Moore Kuehn Encourages FMBI, LWAC, LEGO and FORE Investors to Contact Law Firm
prnewswire.com
2021-06-21 13:15:00NEW YORK, June 21, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: First Midwest Bancorp, Inc. (NASDAQ: FMBI) First Midwest has agreed to merge with Old National Bancorp.
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Foresight Acquisition Corp. - FORE
prnewswire.com
2021-06-05 00:09:00NEW YORK, June 5, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Foresight Acquisition Corp. ("FORE" or the "Company") ( FORE ) relating to its proposed merger with P3 Health Partners. Under the terms of the agreement, FORE will acquire P3 through a reverse-merger, with P3 emerging as a publicly traded company.